Injectable Fibrin Scaffold Improves Cell Transplant Survival, Reduces Infarct Expansion, and Induces Neovasculature Formation in Ischemic Myocardium
Top Cited Papers
- 5 August 2004
- journal article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 44 (3), 654-660
- https://doi.org/10.1016/j.jacc.2004.04.040
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Fibrin Glue Alone and Skeletal Myoblasts in a Fibrin Scaffold Preserve Cardiac Function after Myocardial InfarctionTissue Engineering, 2004
- Taking the Death Toll After Cardiomyocyte Grafting: A Reminder of the Importance of Quantitative BiologyJournal of Molecular and Cellular Cardiology, 2002
- Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death StrategiesJournal of Molecular and Cellular Cardiology, 2001
- Binding of Basic Fibroblast Growth Factor to Fibrinogen and FibrinPublished by Elsevier BV ,1998
- Fibrin Sealant: Scientific Rationale, Production Methods, Properties, and Current Clinical UseVox Sanguinis, 1997
- Alternative Adhesion Sites in Human Fibrinogen for Vascular Endothelial CellsBiochemistry, 1996
- Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy.The Journal of cell biology, 1994
- Fibrin Sealant Adhesive Systems: A Review of Their Chemistry, Material Properties and Clinical ApplicationsJournal of Biomaterials Applications, 1993
- Angiogenic activity of fibrin degradation products is located in fibrin fragment EThe Journal of Pathology, 1992
- A model of acute regional myocardial ischemia and reperfusion in the ratMagnetic Resonance in Medicine, 1989